TSE:7459 (Japan)
Business Description
Medipal Holdings Corp
NAICS : 424210
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Compare
Compare
Traded in other countries / regions
59Z.Germany
•
7459.Japan
•
MAHLY.USA
Description
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.71 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.43 | |||||
| Interest Coverage | 2851.69 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.72 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | -0.8 | |||||
| 3-Year EPS without NRI Growth Rate | -3.3 | |||||
| 3-Year FCF Growth Rate | -0.3 | |||||
| 3-Year Book Growth Rate | 4.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.44 | |||||
| 9-Day RSI | 39.04 | |||||
| 14-Day RSI | 43.54 | |||||
| 6-1 Month Momentum % | -8.75 | |||||
| 12-1 Month Momentum % | -5.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 19.22 | |||||
| Days Sales Outstanding | 80.43 | |||||
| Days Payable | 109.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.29 | |||||
| Dividend Payout Ratio | 0.33 | |||||
| 3-Year Dividend Growth Rate | 5 | |||||
| Forward Dividend Yield % | 2.4 | |||||
| 5-Year Yield-on-Cost % | 3.26 | |||||
| 3-Year Average Share Buyback Ratio | 1.9 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6.61 | |||||
| Operating Margin % | 1.39 | |||||
| Net Margin % | 0.89 | |||||
| ROE % | 5.55 | |||||
| ROA % | 1.71 | |||||
| ROIC % | 5.48 | |||||
| ROC (Joel Greenblatt) % | 21.75 | |||||
| ROCE % | 7.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.65 | |||||
| PE Ratio without NRI | 14.5 | |||||
| Shiller PE Ratio | 14.68 | |||||
| PEG Ratio | 72.5 | |||||
| PS Ratio | 0.13 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| Price-to-Free-Cash-Flow | 10.18 | |||||
| Price-to-Operating-Cash-Flow | 7.04 | |||||
| EV-to-EBIT | 3 | |||||
| EV-to-EBITDA | 2.48 | |||||
| EV-to-Revenue | 0.05 | |||||
| EV-to-FCF | 3.97 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 13.21 | |||||
| Earnings Yield (Greenblatt) % | 33.3 | |||||
| Forward Rate of Return (Yacktman) % | 7.13 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 3,290,921 | ||
| EPS (TTM) (円) | 131.41 | ||
| Beta | 0.43 | ||
| Volatility % | 20.98 | ||
| 14-Day RSI | 43.54 | ||
| 14-Day ATR (円) | 39.395725 | ||
| 20-Day SMA (円) | 1987 | ||
| 12-1 Month Momentum % | -5.84 | ||
| 52-Week Range (円) | 1603 - 2265 | ||
| Shares Outstanding (Mil) | 209.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medipal Holdings Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||